Table 9.
Name of the technique | Clinical indications | Notes |
TOF MR angiography | Cerebral aneurysm | No contrast agent is required |
Stroke | ||
Atherosclerotic carotid disease | ||
Arteriovenous malformation | ||
Peripheral artery disease (less frequently) | ||
ECG-gated fast spin echo MR angiography | Peripheral artery disease | No contrast agent is required. |
Thoraco-abdominal aortic aneurysm | Higher image quality compared to TOF MR angiography in peripheral arterial imaging | |
SSFP MR imaging | Coronary artery disease | No contrast agent is required |
Myocardial viability and function | ||
Pericardial diseases | ||
Renal artery stenosis | ||
Congenital heart diseases | ||
Arterial spin labeling with/without SSFP | Native and transplanted renal renal artery stenosis | No contrast agent is required. |
Renal perfusion | Evaluation of organ perfusion | |
Cerebral blood flow | When combined with SSFP, it can be used as an angiographic imaging | |
Characterization of masses | ||
Phase contrast MR imaging | Imaging of major thoroco-abdominal vascular structures | No contrast agent is required. |
Congenital heart disease | Quantification of blood flow and velocity | |
Renal artery stenosis | ||
Carbon-dioxide angiography | Peripheral artery disease (mostly infra-diaphragmatic) | No contrast agent is required. |
Non-allergenic, non-nephrotoxic, inexpensive. | ||
Neurotoxic, risk of air trapping and distal ischemia |
TOF: Time-of-flight; MR: Magnetic resonance; ECG: Electrocardiography; SSFP: Steady-state free precession.